Sarepta Therapeutics, Inc. SEC filings
Sarepta Therapeutics (SRPT) filed its 10-Q for the quarter ended 30 June 2026 on 5 August 2026. Its latest SEC filing, on 23 September 2026, was an 8-K: material agreement. 21 filings in the last twelve months, each 8-K by what it was about; the 10-K and proxy statement are on the documents page.
In the twelve months since 11 October 2025 Sarepta Therapeutics, Inc. filed 21 documents with the SEC of the kinds listed here: 12 current reports (8-K), about 5 results of operations; 4 officer or director change; 2 material agreement; 1 regulation FD disclosure; 1 shareholder vote; 3 quarterly reports (10-Q), 2 employee share plan registrations (S-8), 1 annual report to shareholders (ARS), 1 additional proxy material (DEFA14A), 1 proxy statement (DEF 14A), 1 annual report (10-K). The latest, filed 23 September 2026: 8-K, material agreement. The 10-K, the 10-Qs and the proxy statement themselves, each with a link to open it, are on the documents page.
| Filed | Form | What it was about | Period or event date | Filing |
|---|---|---|---|---|
| 23 September 2026 | 8-K | Material agreement | 23 September 2026 | EDGAR |
| 5 August 2026 | 8-K | Results of operations | 5 August 2026 | EDGAR |
| 5 August 2026 | 10-Q | quarterly report | 30 June 2026 | EDGAR |
| 28 July 2026 | S-8 | employee share plan registration | EDGAR | |
| 27 July 2026 | 8-K | Officer or director change, Regulation FD disclosure | 23 July 2026 | EDGAR |
| 4 June 2026 | S-8 | employee share plan registration | EDGAR | |
| 4 June 2026 | 8-K | Officer or director change, Shareholder vote | 4 June 2026 | EDGAR |
| 6 May 2026 | 8-K | Results of operations | 6 May 2026 | EDGAR |
| 6 May 2026 | 10-Q | quarterly report | 31 March 2026 | EDGAR |
| 24 April 2026 | ARS | annual report to shareholders | 31 December 2025 | EDGAR |
| 24 April 2026 | DEFA14A | additional proxy material | EDGAR | |
| 24 April 2026 | DEF 14A | proxy statement | 4 June 2026 | EDGAR |
| 2 March 2026 | 10-K | annual report | 31 December 2025 | EDGAR |
| 25 February 2026 | 8-K | Officer or director change | 25 February 2026 | EDGAR |
| 25 February 2026 | 8-K | Results of operations | 25 February 2026 | EDGAR |
| 12 January 2026 | 8-K | Results of operations | 12 January 2026 | EDGAR |
| 19 December 2025 | 8-K | Material agreement, New financial obligation | 18 December 2025 | EDGAR |
| 11 December 2025 | 8-K | Unregistered sale of equity, Other events | 10 December 2025 | EDGAR |
| 8 December 2025 | 8-K | Officer or director change | 7 December 2025 | EDGAR |
| 6 November 2025 | 10-Q | quarterly report | 30 September 2025 | EDGAR |
| 3 November 2025 | 8-K | Results of operations | 3 November 2025 | EDGAR |
Read more
Form 4, Form 144, 13F and Schedule 13D and 13G have their own pages. Prospectus supplements and correspondence are not listed.Source
The company's filing index on EDGAR, read from the SEC's submissions feed.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.